Heartseed Inc., Breakthrough cell therapy for severe heart failure.

As an innovative new treatment option for heart failure, a unique cardiac remuscularization therapy has been invented by Dr. FUKUDA Keiichi, Founder & CEO, Professor at Keio University School of Medicine.

Venture Valuation (VV) interviewed YASUI Kikuo, COO.

Read the Interview

Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?